THC, HHC and THCP are cannabinoids that can affect cannabinoid receptors, but their origins, evidence base and legal background differ.
HHC and THCP were once widely marketed in Europe as legal THC alternatives. In Estonia in 2026, both are scheduled substances. In August 2026, controls were also broadened to a defined semisynthetic cannabinoid group.
This comparison covers origins, research and Estonian law. Human health evidence is particularly limited for HHC and THCP compared with THC.
What is THC?
Tetrahydrocannabinol is cannabis’s best-known psychoactive cannabinoid.
Several related compounds occur in the plant, but intoxicating cannabis discussions usually refer to delta-9-THC.
THC acts through mechanisms including brain CB1 receptors and can cause:
- altered perception;
- relaxation or euphoria;
- impaired attention and reactions;
- coordination difficulties;
- increased appetite;
- anxiety, panic or discomfort in some people.
Effects depend on the individual, product composition, amount and other factors.
Of these three compounds, THC has the most human research.
What is HHC?
Hexahydrocannabinol is chemically related to THC. Trace natural occurrence is possible, but commercial products generally use chemical processing, making HHC commonly described as semisynthetic.
Products became prominent in Europe as purported legal alternatives made from hemp-derived CBD. HHC also affects cannabinoid receptors and may produce THC-like effects.
High-quality human evidence is much more limited. Different HHC forms can differ in activity, and product composition may not match labels.
It should not simply be described as a milder or safer THC.
What is THCP?
Tetrahydrocannabiphorol is structurally similar to THC and has been identified in trace amounts in cannabis. Laboratory findings of substantially higher affinity for human CB1 receptors attracted attention.
This prompted the misleading claim that it is ’33 times stronger’. Receptor affinity is not the same as experienced effect.
The approximately 33-fold difference comes from laboratory binding measurements, not proof of 33-fold intoxication from an equal amount.
Human effects remain insufficiently studied for precise claims often made in marketing.

Another easily confused compound is THCA, whose chemistry and scheduling require separate explanation.
Quick comparison
THC
- occurs naturally;
- is the plant’s principal intoxicating cannabinoid;
- has a relatively substantial human evidence base;
- is controlled in Estonia.
HHC
- may occur in traces, but commercial supply is predominantly semisynthetic;
- can produce THC-like cannabinoid effects;
- has less high-quality human health evidence;
- is scheduled in Estonia.
THCP
- can occur naturally in very small amounts;
- has strong CB1 affinity in laboratory experiments;
- has limited human research;
- is scheduled in Estonia.
Was HHC previously legal?
Its emergence created considerable confusion.
It entered several European markets before being individually named in legislation and was promoted as legal cannabis.
In Estonia it is now expressly scheduled, so calling it a legal THC alternative is inaccurate.
Is THCP legal in Estonia?
Online claims such as ‘legal THC’, or natural origin, do not establish permission. THCP is individually named in Estonia’s schedules.
It is not an unrestricted legal retail alternative.
What changed in August 2026?
An amendment effective on 14 August 2026 added a group to Schedule VI:
semisynthetic cannabinoids, described as cannabinol derivatives. The aim was to address repeated introductions of THC-like compounds marketed while individual scheduling caught up.
The definition covers a structural group rather than one new compound. Our separate THCV overview explores another related topic.
CBD was excluded from the group, but product-specific food, extract and other requirements still apply.
What about the 0.3% industrial hemp threshold?
Estonia’s schedule includes an exception for compliant varieties in the EU common catalogue with THC no higher than 0.3%. This primarily concerns industrial hemp, not unrestricted psychoactive products merely derived somewhere along the supply chain from hemp.
Actual contents and classification determine status. See our Estonian cannabis law overview.
Why does hemp origin not establish legality?
Marketing phrases common particularly in the US include:
- hemp-derived THC;
- legal THC;
- THC alternative;
- legal high;
- hemp cannabinoid.
These are marketing terms, not Estonian legal categories.
Making a psychoactive compound from hemp-derived CBD does not automatically permit the final substance.
HHC illustrates this distinction: the starting material may be CBD, while HHC itself is controlled.
Is HHC safer than THC?
Current knowledge does not support a confident claim.
Human studies and long-term evidence are limited.
Unregulated products also raise questions about:
- actual HHC content;
- which isomers are present;
- manufacturing by-products;
- residual solvents, catalysts or other substances;
- whether the label matches the contents.
Newer, hemp-derived or formerly marketed as legal does not mean safer.
Is THCP much more dangerous?
Human evidence is insufficient for a reliable numerical comparison.
Strong receptor binding shows biological activity but does not establish an exact multiple of human effect.
Be sceptical of precise potency claims unsupported by clinical evidence.
What risks do psychoactive cannabinoids carry?
Possible adverse effects include:
- anxiety and panic;
- dizziness;
- confusion;
- reduced attention and reaction speed;
- impaired coordination;
- heart-rate changes;
- nausea;
- marked drowsiness.
Risk assessment is harder for newer compounds with little toxicology or clinical data.
Unregulated composition adds another uncertainty.
Can someone drive under their influence?
Impaired attention, judgment, reaction and coordination make driving and other hazardous tasks unsafe.
Driving associated with controlled-substance use can also have legal consequences.
Why does a laboratory certificate not establish legality?
A certificate of analysis describes what a laboratory found in a particular sample.
It may help assess composition, but laboratory analysis does not determine legal status. A clean result or hemp-derived starting material does not authorise a scheduled compound.
Frequently asked questions
Is HHC legal in Estonia?
No. HHC is individually scheduled in Estonia.
Is THCP legal in Estonia?
THCP is also individually scheduled.
Is THC legal in Estonia?
THC and controlled cannabis are restricted outside statutory exceptions.
The industrial hemp exception does not extend automatically to psychoactive THC products.
Are HHC and THC the same?
No. HHC and THC are related but distinct, with much less evidence about HHC pharmacology and human health.
Is THCP 33 times stronger than THC?
That claim cannot be made about human effects.
The roughly 33-fold affinity difference is a laboratory measurement, not proof of exactly 33-fold effects in people.
Is CBD also prohibited?
CBD itself is excluded from the 2026 group. Medicines, food, novel food and other product rules still apply, so not every CBD product is freely marketable.
Summary
These compounds are not interchangeable names. THC is the most studied and cannabis’s principal psychoactive cannabinoid.
Commercial HHC is predominantly semisynthetic, with substantially less human evidence.
THCP can occur in traces and has strong laboratory receptor affinity, but the familiar ’33 times stronger’ claim misrepresents what that means.
THC, HHC and THCP are not freely sold legal THC alternatives in Estonia in 2026.
The August 2026 group-based controls also address newer structurally related derivatives without necessarily waiting for each individual name.
